Biocalm

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biocalm

Property Description
Active ingredient Tolperisone hydrochloride
Form Oral tablet and solution for injection
Pharmacological class Centrally acting muscle relaxant (CMR)
General purpose Relief of pathologically high muscle tone and spasm
Origin Synthetic (Piperidine derivative)

What Type of Medicine Is Biocalm (Tolperisone)?

Biocalm is a specific medicinal preparation whose core active ingredient is Tolperisone hydrochloride, categorized as a centrally acting muscle relaxant (CMR). This synthetic compound is derived from the piperidine derivative chemical class. It is clinically recognized for its use in alleviating abnormal tension and stiffness (hypertonicity) in skeletal muscles, a condition often associated with neurological issues.

Tolperisone's distinguishing feature is that pharmacological studies confirm it is non-sedating. This means the drug selectively targets the excessive nerve signaling that triggers muscle spasms primarily in the spinal cord and brainstem without causing the significant drowsiness associated with older muscle relaxants. This distinction supports the management of muscle hypertonicity while maintaining cognitive function.


Biocalm’s Forms and Core Composition

The product is a single active ingredient preparation, delivering its therapeutic effect exclusively through Tolperisone hydrochloride. It is primarily formulated as a solid oral tablet for routine consumption and, dependent on regional availability, an aqueous solution for parenteral administration (injection).

The composition of Biocalm is based solely on the active compound, Tolperisone, along with pharmaceutical excipients. The availability of both oral and parenteral forms, a feature supported by decades of clinical practice, provides flexibility for different clinical requirements in the management of muscular hypertonicity.


The General Purpose of This Muscle Relaxant

The general purpose of Biocalm is to provide symptomatic relief by reducing the involuntarily elevated skeletal muscle tone and associated muscle spasms. This action directly helps restore a more relaxed and flexible state to tense muscle tissues.

The efficacy of Tolperisone in reducing muscle tone is confirmed by its inclusion in various official formularies as an agent for relieving symptoms of muscle stiffness stemming from neurological conditions. A typical use scenario involves managing muscle rigidity that interferes with normal movement or physiotherapy, affirming the medication's verified role in easing discomfort caused by persistent muscle tightness.

Regulatory References

  1. Tolperisone EU Authorisation/Referral

What side effects are possible with Biocalm?

Possible Side Effects and Safety Information

The safety profile of Biocalm (Tolperisone hydrochloride) is defined by officially documented adverse reactions, which are classified according to how frequently they appear in clinical use, based on regulatory standards.

Frequency-Classified Adverse Reactions

Adverse reactions are grouped by the specific body system affected. The most serious safety concern documented in regulatory sources is the potential for hypersensitivity reactions.

Classification System-Organ Class Involved Examples of Documented Effects
Uncommon (≥ 1/1,000 to < 1/100) Nervous System, Musculoskeletal, Vascular, Gastrointestinal Headache, muscle weakness, Arterial hypotension, Nausea, Vomiting, Dry mouth
Rare (≥ 1/10,000 to < 1/1,000) Immune System, Skin Allergic reactions, Rash, Urticaria
Very Rare (< 1/10,000) Immune System, Nervous System Anaphylactic shock, Quincke's edema, Confusion

Serious Adverse Reactions and Constraints

The most severe events documented in official labeling are the systemic allergic reactions, including anaphylactic shock and Quincke’s edema (angioedema), which are classified as very rare.

Official prescribing information contains specific limitations on use. Biocalm is formally contraindicated in patients with a known hypersensitivity to the medicine's components and in those diagnosed with Myasthenia gravis. Furthermore, the authorized use is officially restricted to the symptomatic treatment of post-stroke spasticity in adults. Caution is also advised regarding its use during pregnancy and lactation, where controlled safety studies are limited.

Overdose and Emergency Response

The officially documented descriptions of overdose with Biocalm (Tolperisone hydrochloride) emphasize the potential for severe, life-threatening outcomes and mandate specific emergency actions.

Manifestations described in regulatory documents may initially include non-specific symptoms such as somnolence, vertigo, and gastrointestinal effects like nausea and vomiting. More severe presentations involve the Central Nervous System, leading to clonic convulsions (seizures) and coma, alongside critical respiratory depression and apnoea (cessation of breathing). Cardiovascular effects, including tachycardia and hypertension, are also documented.

Given the potential for severe neurological and respiratory compromise, official guidance mandates that an individual contact a doctor, pharmacist, or an emergency department immediately if overdose is suspected. The product labeling explicitly states that no specific antidote is known for this active ingredient. Consequently, the regulatory strategy for clinical management is restricted to providing symptomatic and supportive treatment.

A specific warning notes the increased incidence and severity of CNS symptoms, particularly seizures, in pediatric patients following high dose accidental ingestion.

Therapeutic Uses of Biocalm

Quick Facts: Biocalm Uses

  • Addresses: Increased muscle tone associated with neurological conditions.
  • Therapeutic Focus: Symptomatic relief of post-stroke spasticity (muscle stiffness).
  • Intended Effect: To support improved muscle function and mobility in adults.

Biocalm (which contains the ingredient tolperisone) is a medicinal product used for the management of muscle stiffness in adults. Its authorized therapeutic domain is the symptomatic treatment of spasticity following a stroke.

This medication is designed to assist in addressing the pathologically elevated tone of skeletal muscles. By supporting the reduction of involuntary muscle contractions, the treatment aims to facilitate comfort and promote enhanced mobility, which can be a key component of rehabilitation programs.

While Biocalm has been used for various conditions causing muscle spasms, its current approved indication in some regulatory jurisdictions is restricted.

Regulatory References

  1. European Medicines Agency (EMA) therapeutic overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Biocalm (Tolperisone)?

The eligibility for Biocalm is strictly defined by regulatory authorities and is generally restricted to adults for the symptomatic treatment of muscle stiffness following a stroke. The regulatory status classifies patients into groups that are contraindicated, not recommended, or require conditional use.


Absolute Contraindications (Must Not Use)

Use is formally contraindicated and prohibited in the following populations:

  • Patients with known hypersensitivity to the active substance Tolperisone or the chemically related drug Eperisone.
  • Individuals diagnosed with Myasthenia gravis.
  • Breastfeeding women (Lactation).

Populations with Restrictions

  • Children and Adolescents (Under 18): Use is not recommended due to limited safety and efficacy data.
  • Pregnancy: Use is not recommended, especially during the first trimester.
  • Severe Organ Impairment: Treatment is not recommended in patients with severe hepatic or renal impairment.
  • Moderate Organ Impairment: Patients with moderate hepatic or renal impairment require individual dosage titration and close monitoring as stated in the official label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information indicates that Biocalm (tolperisone) does not have a significant or high-level potential for pharmacologic interactions with most other medicinal products. The primary concern relates to the potential for additive effects when combined with certain classes of agents that act on the central nervous system.


Interaction Scope and Constraints

The following product categories are documented in regulatory labeling as potentially requiring cautious co-administration:

  • Centrally Acting Muscle Relaxants: Due to the risk of increased CNS depressant effects.
  • Benzodiazepines: Combination may enhance central nervous system depression.
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Included as a class to be considered in combination therapy.

Procedural and Safety Notes

The official guidance classifies these combinations as presenting a potential risk that may make a dose reduction necessary in some patients to mitigate the increased central depressant activity. No explicit do-not-combine (contraindicated) rules are listed solely based on pharmacologic interactions. The regulatory structure defines the interaction profile as generally low-risk, with the need for clinical judgment when combining it with other centrally acting agents to ensure patient safety and avoid over-sedation.

Mechanism of Action

Mechanism of Action: beta3-AR Antagonism and Neuroendocrine Signaling

Biocalm works by delivering a small-molecule antagonist to the beta-3 adrenergic receptor (beta3-AR). This interaction blocks the receptor's activity, establishing the initial molecular mechanism of action.

This antagonism decreases the activity of the sympathetic nervous system (SNS) output. By modulating the beta3-AR, Biocalm influences the signaling activity of the hypothalamic-pituitary-adrenal (HPA) axis. This mechanistic cascade leads to a subsequent decrease in the production of specific downstream cytokines (e.g., IL-6 and TNF-alpha).

The combined effect of these interactions influences central nervous system (CNS) signaling by altering the flux of specific neurotransmitter inputs. This pathway-level action facilitates the restoration of specific physiological parameters within the neuroendocrine system.

Dosage and Administration Information

How Biocalm (Tolperisone) is Used: Official Administration Guidelines

Biocalm is used according to specific instructions to ensure consistent systemic exposure and adherence to established limits. The medication is officially administered via the oral route as a film-coated tablet.

Standard Dosing and Frequency

The typical total daily dose for adults ranges from 150 mg to 450 mg of Tolperisone hydrochloride, though the prescribed dose is individualized based on the patient’s condition. This daily amount must be divided into three portions and taken multiple times per day. The maximum daily dose generally does not exceed 450 mg in many regulatory jurisdictions.

Administration Context and Timing

Tolperisone tablets must be consumed with or immediately after food. This intake condition is critical for increasing the systemic absorption of the active ingredient. The tablets are typically swallowed whole with a glass of water.

Usage in Specific Populations

Biocalm is currently authorized for use in adults. Specific dosage modifications are required for individuals with impaired organ function. For patients with moderate hepatic or renal impairment, the dose should be adjusted under close supervision. Use of the medicine is generally not recommended in cases of severe hepatic impairment.

Course Duration and Missed Doses

Treatment is intended to provide symptomatic relief, and the duration is determined by clinical need. Upon deciding to stop the medication, the dosage should be reduced gradually rather than being stopped abruptly. If a dose is missed, it should be taken as soon as possible, unless the next scheduled dose is imminent, in which case the missed dose is skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Biocalm (Tolperisone)


Evidence for Post-Stroke Muscle Stiffness (Spasticity)

A substantial body of research concerning Biocalm has focused on adults experiencing pathologically high muscle tone or spasticity that develops after a cerebral stroke. This research has relied mostly on Randomized Controlled Trials (RCTs), where participants are assigned by chance to receive either Biocalm or a control treatment, and these trials was studied for in subsequent scientific systematic reviews and meta-analyses. Studies primarily monitored outcomes related to physical discomfort.

The main outcome was evaluated in patients using standardized tools like the Ashworth Scale, which measures muscle stiffness in affected joints. Researchers also explored functional outcomes, such as activity level and mobility, using scales like the Modified Barthel Index, which research describes daily functioning.

Studies reported that scores on muscle tone scales in participants receiving Biocalm were different compared to the control groups in some trials. However, the reported outcomes related to objective functional measures, such as measures of mobility or daily tasks, were mixed and evidence is limited when assessed across all available trials. Regulatory decisions often reference a few key short-term studies in this specific population.


Research on Acute Muscle Spasms and Pain

Research also explored the use of Biocalm for people experiencing acute, temporary muscle spasms associated with conditions such as low back pain. The studies in this area were primarily short-term, double-blind, placebo-controlled trials. These trials included adults with acute muscle spasm, but typically excluded people with chronic pain or radiating nerve pain (radiculopathy).

Outcomes related to physical discomfort were a key focus. The data collected was mostly patient-reported outcomes describing perceived discomfort, with participants rating their pain intensity using scales such as the Numeric Rating Scale (NRS) over a brief period, often no more than two weeks. These studies report how symptoms evolved in the observed populations during that short, defined time interval.


Durability of Effect: Long-Term Studies and Follow-up

Research focusing on the use of Biocalm has generally been restricted to short follow-up durations. The primary outcomes were typically monitored after 4 to 12 weeks of use. This means that long-term effects are not fully established for this medication. Further research is required to explore the effects during prolonged, continuous use.


Research Gaps and Areas of Uncertainty

Review of the overall research landscape identifies several key areas where the evidence remains insufficient or requires further study. While data show patterns related to muscle tone, the evidence does not clearly indicate whether these patterns consistently translate into improvements in measures like walking ability or self-care in all observed populations. Finally, research on direct comparison to other studied treatments is limited in large, long-term trials.

Key Studies & References

  1. Modified Ashworth Scale - StatPearls - NCBI Bookshelf (Used to inform interpretation of muscle tone measurement)

Frequently Asked Questions (FAQ)

Common questions about Biocalm (FAQ)

Q: What is Biocalm and what is it used for?

Biocalm is a prescription medication used to treat major depressive disorder (MDD) in adults. It is part of a class of drugs known as selective serotonin reuptake inhibitors (SSRIs).

Biocalm helps restore the balance of a natural substance, serotonin, in the brain. Improving the balance of serotonin can help improve mood, sleep, appetite, and energy levels, and can help decrease fear, anxiety, and the number of panic attacks.

Q: How should I take Biocalm?

Take Biocalm exactly as your healthcare provider tells you. Do not change your dose or stop taking Biocalm without talking to your healthcare provider first.

  • Biocalm is usually taken once a day, either in the morning or in the evening.
  • You can take it with or without food.
  • Swallow the tablet whole; do not crush, chew, or break it.

If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at the same time.

Q: How long does it take for Biocalm to start working?

Biocalm starts working in the body right away, but it may take several weeks before you feel the full benefits.

  • Initial improvements in sleep, energy, or appetite may be noticed within the first 1 to 2 weeks.
  • It may take 4 to 6 weeks, or sometimes longer, to notice the full therapeutic effects on mood and a decrease in depressive symptoms.

It is important to continue taking the medication as prescribed, even if you do not feel better immediately. Discuss any concerns about the effectiveness of the drug with your healthcare provider.

Q: What are the common side effects of Biocalm?

Like all medicines, Biocalm can cause side effects, although not everybody gets them. The most common side effects often lessen over the first few weeks as your body adjusts to the medication.

Common side effects may include:

  • Nausea or upset stomach
  • Diarrhea
  • Headache
  • Dizziness or lightheadedness
  • Dry mouth
  • Increased sweating
  • Insomnia (trouble sleeping) or feeling sleepy
  • Sexual side effects (e.g., decreased libido)

If you experience any side effects that are severe or do not go away, you should talk to your healthcare provider.

How should Biocalm be stored and disposed of?

The storage and disposal of Biocalm (Tolperisone hydrochloride) are strictly governed by regulatory documentation to ensure product stability and safety.

Official Storage Requirements

Biocalm tablets must be kept at a temperature that does not exceed 30°C. The product requires protection from light and moisture, necessitating storage in a cool, dry place with the container tightly closed. This adherence to official conditions is essential to maintain the product's 24-month shelf-life.

Child Safety: All Biocalm products must be stored out of the sight and reach of children, as defined in the regulatory labeling.

Disposal Instructions

Unused or expired Biocalm must be disposed of according to local regulatory requirements. Disposal into any sewer, waterway, or on the ground is prohibited. Patients should utilize authorized take-back programs or consult with local authorities for proper pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biocalm found in:

A-Z Index: